Peer Review History
| Original SubmissionFebruary 10, 2024 |
|---|
|
PONE-D-24-04377Factors associated with postoperative visual function after rhegmatogenous retinal detachment with foveal detachmentPLOS ONE Dear Dr. yokoyama, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscrip by May 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jiro Kogo Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file)” 3. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and its Supporting Information files. Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. On Page 9, Line 85, you mentioned“33 eyes of 32 patients”, which is not consistent with “the 33 eyes of 34 patients”mentioned in the methods in the abstract. Please explain? If so, I suggest that it is better to include 32 eyes of 32 people and only one eye of each patient to avoid interference. 2. On Page 9, Line 89, The exclusion criteria did not include high myopia, but did this study include high myopia? After all, the postoperative macular morphology and visual function recovery of high myopia and non-high myopia are different. 3. On Page 14, Line 135-136, you state that "The duration after recognizing visual dysfunction (in days) was defined as the period during which the patient acknowledged central vision dysfunction" this is only true if the macula is involved. Please correct this. 4. On Page 19, Line 178, It would be helpful to describe in the manuscript and tables how many eyes were followed up at 3 months, 6 months, and 12 months. These images are good in the manuscript, but it would also be helpful to have a preoperative photograph. Reviewer #2: In this article, authors try to reveal factors related to the visual outcomes after repair of macula-involving RRDs including the analyses of retinal sensitivity, and compare their results with other previous papers. Their methods sound reasonable and the results are within expectations, however, I would like to propose several points for further revision particularly for more distinct expression of the results and for discussion to obtain relevance for their results that are not necessarily consistent with the previous ones. Additionally, I would like to ask authors to revise the text to remove descriptions duplicating in two or more sections such as the same thing expressed in the method and the result. 1. For evaluation of visual outcomes after repair of macula-involving RRD, methods of SRF drainage and use of dye are important factors since some previous studies have reported differences in the visual outcomes or morphology of the ORLs depending on the use of PFCL, SO, ICG, or creation of an intentional break for drainage. Please describe these aspects in details in the method as well as in the discussion particularly in comparison with other studies presented in Table 5. 2. Abstract: Methods “33 eyes of 34 patients” should be a mistake. 3. Abstract, the 1st line of the conclusions “The factors related to….. differ”: it is not clear what this sentence means. I guess this sentence could be deleted. 4. Results are presented for both univariate analyses and multiple regression analyses in three paragraphs. They might be understood better if subtitles for each type of analyses are provided, such as ‘Univariate linear regression analysis’ and ‘Multiple regression analysis’. Plus, as a rule of those statistical methods, results of the univariate analysis would be better presented briefly in a very short paragraph because they only serve to show which of the factors were selected for the multiple regression analysis (Table 2 shows everything clearly without explanation in the main text) and authors should concentrate on the results of the multivariate analysis. Otherwise, the descriptions of the results are quite long and complicated and may give readers a wrong message that the results of the univariate analyses have some important meaning. 5. Association of each factor with BCVA, metamorphopsia scores and retinal sensitivity is presented with p-values, but it is not clear whether the association was positive or negative. Please present each association specifically as worse or better visual function. As far as I understood, each factor seems to be related to ‘worse’ BCVA, ‘higher’ metamorphopsia scores and ‘lower’ retinal sensitivity. To help readers understand these aspects correctly, I would also like to request authors to provide the mean values (with SD) of each visual function regarding each factor (at least for the factors that were proved to affect visual function in the multivariate analysis as shown in Table 3) in the table in addition to r and P values. 6. Among the factors proved to be associated with postoperative visual function, ILM peeling is the only one which surgeons can decide to do or not to do. In this meaning, the result regarding ILM peeling is the most suggestive point in this article. Although it was performed on the surgeons’ discretion, I guess there might have been some trend for the decision of ILM peeling such as the time when PPV was performed or the distribution/chronicity of the RRD. Please provide some information and comment on this aspect. 7. In the 1st paragraph of the discussion, a result from univariate analysis is mentioned as being consistent with the result presented by Park et al; however, as a principle and as proposed above in the comment 4, the factors which did not have significance in the multivariate analysis should not be considered as a meaningful result even if significance was shown in the univariate regression analysis. 8. One of the important aspects of this study is the difference from other studies in terms of the postoperative recovery of metamorphopsia and retinal sensitivity as presented in Table 5. I would like to ask authors to add some interpretations and comments to explain these discrepancies. Without such discussions, the results presented in this article might lose its relevance. One possible aspect to explain the discordance might be related to those as suggested in the comment No 1 above. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-04377R1Factors associated with postoperative visual function after rhegmatogenous retinal detachment with foveal detachmentPLOS ONE Dear Dr. yokoyama, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 17 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jiro Kogo Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Authors have addressed the previous reviewers’ comments well and consequently the manuscript has been revised well. However, I still find several points to be revised further mainly in the parts that have been changed by revision. 1. Abstract: “Conclusions” are written in a style like a copy of the results. Please revise the conclusions to summarize the results briefly in one or two sentences. 2. Statistical analysis: Lines 171-173 ‘including….. at 1 year postoperatively’ could be omitted because they duplicate with lines 176-177. 3. Results; Multiple regression analysis: I would like to request authors to revise whole sentences in an organized way. For example, lines 197-201 should be omitted because the same thing has been described in the methods; for each of BCVA, vertical and horizontal metamorphopsia, descriptions of ‘significantly associated with’ and ‘which was associated with significantly worse …’ should be presented in a single and simple sentence to avoid duplications; lines 204-207 might be ‘ILM peeling and longer duration were associated with higher vertical metamorphopsia score’, not ‘metamorphopsia was associated with ILM peeling and longer duration’; same in lines 208-211; ‘1 year postoperatively’ appears too often; etc. 4. 1st paragraph of discussion: Usually discussions start with a summary of the results in the current study, whereas the present writing of this paragraph sounds like an introduction to the report by Park et al. Please revise this paragraph to focus on the authors’ own results and compare them with previous literature. It might be recommended to create a new paragraph as the 1st to describe the total results briefly and move on to the 2nd in which factors related to postsurgical visual acuity are discussed. 5. Reference 18 by Abdullah et al: in this paper, all eyes were treated using both PFCL and SO, which may have had some or significant impact on the retinal function and macular morphology particularly in the ILM-peeled area as has been suggested by some previous studies and meta-analysis including the one assessing metamorphopsia and discontinuity of the ORLs between eyes treated with and without PFCL. When authors compare their results with previous literature, those difference in the details of surgical procedures that may potentially affect the results should be carefully discussed. 6. Discussion, lines 274-281: authors discuss that the discontinuity of Ez lines was recovered in many cases from 3 months to 1 year, while the Ez status at 3 months was predictive of retinal sensitivity at 1 year. To me, these two descriptions do not fit each other well and it is not clear how they are connected to each other in the structure of the paragraph. 7. In the newly added paragraph in Discussion part (from the line 296), some points are discussed very well regarding the discrepancy in postoperative metamorphopsia in comparison with previous reports. However, the first point proposed by the authors (preoperative RRD status and symptom duration) may need to show some trend that those status were not typical (if any) among their patients compared to other studies. 8. The last point in the same paragraph to note the difference in the fluid drainage techniques (lines 310-312): If this aspect affected the results, it could be interpreted that drainage from the original break using endoscopy had negative impact on the postoperative recovery of metamorphopsia and retinal sensitivity. Is it true? Personally, I do not think so because results presented in some previous literatures showed better outcomes after drainage from the original break than drainage from posterior retinotomy site, although I do not know if there is any previous report to show advantage or disadvantage when endoscopy is utilized. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-24-04377R2Factors associated with postoperative visual function after rhegmatogenous retinal detachment with foveal detachmentPLOS ONE Dear Dr. yokoyama, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 29 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jiro Kogo Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Authors have addressed the former reviewers’ comments well, while further problems may have arisen in association with the revised parts. 1. The first paragraph of Discussion is very long and does not focus on a single theme. As pointed out in the previous review, please present a brief summary of the current study in the first paragraph (never go beyond it), and then discuss each of the details in comparison with previous literatures in the following paragraphs. Please stick to the rule of writing to focus on one particular topic in each paragraph. 2. Lines 242-243: In which study were “duration after recognizing visual dysfunction and the postoperative status of the EZ line not identified as associated factors? In the current study, those factors were shown to be associated with visual outcomes as illustrated in Table 3, then were they not identified in Park’s report? Please note this point clearly. This confusion occurs partly due to the inappropriate configuration of the paragraphs as suggested above. 3. Lines 260-270: The newly added sentences (lines 260-267; seems too long and interferes the flow of the discussion) and the next sentence (“The findings of the current study also indicate that ….”) do not logically connected to each other smoothly. The structure of discussion should be re-considered for this paragraph. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Factors associated with postoperative visual function after rhegmatogenous retinal detachment with foveal detachment PONE-D-24-04377R3 Dear Dr. Yokoyama We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Jiro Kogo Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-04377R3 PLOS ONE Dear Dr. yokoyama, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Jiro Kogo Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .